Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression ; volume:5 ; number:1 ; day:3 ; month:5 ; year:2019 ; pages:1-8 ; date:12.2019
npj Parkinson's Disease ; 5, Heft 1 (3.5.2019), 1-8, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-019-0079-3
- URN
-
urn:nbn:de:101:1-2019070509334271310597
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pereira, Joana B.
- Weintraub, Daniel
- Chahine, Lana
- Aarsland, Dag
- Hansson, Oskar
- Westman, Eric
- SpringerLink (Online service)
Other Objects (12)
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Novel insights regarding the measurement properties of the SCOPA-AUT
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Novel insights regarding the measurement properties of the SCOPA-AUT
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements